Support : Publications : Chronolog Archives : July/August 2004

Now Available on Dialog DataStar: New Source of Regulatory Information for the Pharmaceutical and Devices Industries

Dialog has launched the Regulatory Affairs Journals (PHRJ), a new database on Dialog DataStar. This new file includes two publications from PJB Publications, the renowned publisher of Scrip and Pharmaprojects:

• Regulatory Affairs Journal ­ Pharma and
• Regulatory Affairs Journal ­ Devices

Founded in 1990, The Regulatory Affairs Journal ­ Pharma has established an international reputation as the primary source of regulatory intelligence, news and opinion for the pharmaceutical, biotech and veterinary industries, as well as government health authorities and the regulatory agencies. The Regulatory Affairs Journal ­ Devices fills the same role for the medical device and in vitro diagnostics sectors worldwide.

Topics covered by both journals are:

• regulatory agencies
• policy and legislation
• application requirements and guidelines
• research and development
• international harmonization
• vigilance and safety issues
• ADR reporting, post-authorization activities and requirements
• trade and environmental issues
• health care systems and priorities
• impact on regulation and marketing
• pharmaceutical/heath care law

Benefits of RAJ Pharma and RAJ Devices include:

• Fully referenced coverage of regulatory change worldwide
  
  
• Expert commentary from regulatory opinion leaders
  
  
• Training and management briefing materials on essential aspects of regulation
  
  
• Consolidated regulatory material from sources worldwide
  
  
• A clear, concise format that saves you time through provision of carefully researched articles
  
  

RAJ Pharma is updated monthly and RAJ Devices bimonthly. For further information on these publications and guidance on searching them, refer to the Datasheet for the Regulatory Affairs Journal database (PHRJ) or the Dialog DataStar Database of Databases, BASE. Search for BASE-PHRJ. For additional information on journal content, visit www.rajpharma.co.uk.

top